|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - CRISPR Therapeutics AG (CRSP)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-06-17 Sale |
2019-06-19 4:15 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
20,000 | $46 | $920,000 | 203,058 (Direct) |
View |
| 2019-06-10 Sale |
2019-06-12 4:16 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
50,000 | $45 | $2,250,000 | 898,007 (Direct) |
View |
| 2019-04-29 Sale |
2019-05-01 4:05 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
20,000 | $42.03 | $840,600 | 223,058 (Direct) |
View |
| 2019-03-01 Sale |
2019-03-05 5:59 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
85,220 | $40.4 | $3,443,037 | 1,024,534 (Direct) |
View |
| 2019-02-25 Sale |
2019-02-27 4:10 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
14,780 | $40 | $591,233 | 1,033,227 (Direct) |
View |
| 2018-12-18 Sale(A) |
2019-01-18 4:32 pm |
CRISPR Therapeutics AG | CRSP | EMSTER KURT VON Director |
62,925 | $29.7 | $1,869,168 | 1,171,268 (Indirect) |
View |
| 2019-01-08 Sale |
2019-01-10 4:09 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
100,000 | $35.02 | $3,502,385 | 1,130,697 (Direct) |
View |
| 2018-12-26 Purchase |
2018-12-28 4:34 pm |
CRISPR Therapeutics AG | CRSP | Vertex Pharmaceuticals (Europe) Ltd VERTEX PHARMACEUTICALS INC 10% Owner |
40,198 | $24.93 | $1,002,194 | 5,380,940 (Direct) |
View |
| 2018-12-21 Purchase |
2018-12-26 4:35 pm |
CRISPR Therapeutics AG | CRSP | Vertex Pharmaceuticals (Europe) Ltd VERTEX PHARMACEUTICALS INC 10% Owner |
90,742 | $24.08 | $2,184,960 | 5,340,742 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 4:22 pm |
CRISPR Therapeutics AG | CRSP | EMSTER KURT VON Director |
72,934 | $29.85 | $2,176,898 | 1,234,193 (Indirect) |
View |
| 2018-07-03 Sale |
2018-07-05 6:25 pm |
CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director |
7,500 | $62 | $465,000 | 88,017 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-06-17 Exercise |
2019-06-19 4:15 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
20,000 | $1.81 | 203,058 (Direct) |
View |
| 2019-06-17 Exercise |
2019-06-19 4:15 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
20,000 | $1.81 | 203,058 (Direct) |
View |
| 2019-06-11 Option Award |
2019-06-13 8:49 pm |
N/A 2029-06-11 |
CRISPR Therapeutics AG | CRSP | High Katherine A Director |
30,000 | $43.52 | 30,000 (Direct) |
View |
| 2019-06-11 Option Award |
2019-06-13 5:07 pm |
N/A 2029-06-11 |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
15,000 | $43.52 | 15,000 (Direct) |
View |
| 2019-06-11 Option Award |
2019-06-13 5:05 pm |
N/A 2029-06-11 |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
15,000 | $43.52 | 15,000 (Indirect) |
View |
| 2019-06-11 Option Award |
2019-06-13 5:05 pm |
N/A 2029-06-11 |
CRISPR Therapeutics AG | CRSP | Greene John Director |
30,000 | $43.52 | 30,000 (Direct) |
View |
| 2019-06-11 Option Award |
2019-06-13 5:04 pm |
N/A 2029-06-11 |
CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director |
15,000 | $43.52 | 15,000 (Direct) |
View |
| 2019-06-11 Option Award |
2019-06-13 5:04 pm |
N/A 2029-06-11 |
CRISPR Therapeutics AG | CRSP | George Simeon Director |
15,000 | $43.52 | 15,000 (Direct) |
View |
| 2019-06-01 Tax Withholding |
2019-06-04 4:25 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
741 | $35.57 | 165,801 (Direct) |
View |
| 2019-04-29 Exercise |
2019-05-01 4:05 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
20,000 | $1.81 | 223,058 (Direct) |
View |
| 2019-04-29 Exercise |
2019-05-01 4:05 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
20,000 | $1.81 | 223,058 (Direct) |
View |
| 2019-03-05 Option Award |
2019-03-07 4:17 pm |
N/A 2029-03-05 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer |
45,000 | $40.87 | 45,000 (Direct) |
View |
| 2019-03-05 Option Award |
2019-03-07 4:14 pm |
N/A 2029-03-05 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN CFO |
75,000 | $40.87 | 75,000 (Direct) |
View |
| 2019-03-05 Option Award |
2019-03-07 4:14 pm |
N/A 2029-03-05 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
65,000 | $40.87 | 65,000 (Direct) |
View |
| 2019-03-05 Option Award |
2019-03-07 4:12 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W See Remarks |
10,000 | $40.87 | 75,000 (Direct) |
View |
| 2019-03-05 Option Award |
2019-03-07 4:12 pm |
N/A 2029-03-05 |
CRISPR Therapeutics AG | CRSP | Ho Tony W See Remarks |
75,000 | $40.87 | 75,000 (Direct) |
View |
| 2019-03-05 Option Award |
2019-03-07 4:11 pm |
N/A 2029-03-05 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
250,000 | $40.87 | 250,000 (Direct) |
View |
| 2019-03-01 Tax Withholding |
2019-03-05 5:57 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
748 | $39.97 | 166,542 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-03 4:32 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer |
20,000 | $29.87 | 20,000 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-03 4:32 pm |
N/A 2029-01-01 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer |
20,000 | $29.87 | 20,000 (Direct) |
View |
| 2018-12-07 Exercise |
2018-12-11 4:29 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
21,500 | $1.81 | 243,058 (Direct) |
View |
| 2018-12-07 Exercise |
2018-12-11 4:29 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
21,500 | $1.81 | 243,058 (Direct) |
View |
| 2018-12-01 Tax Withholding |
2018-12-03 5:29 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
741 | $38.33 | 145,790 (Direct) |
View |
| 2018-09-01 Tax Withholding |
2018-09-04 6:33 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
741 | $56.67 | 146,531 (Direct) |
View |
| 2018-08-01 Exercise |
2018-08-03 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W See Remarks |
37,500 | $0 | 37,500 (Direct) |
View |
| 2018-08-01 Tax Withholding |
2018-08-03 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W See Remarks |
14,631 | $48.43 | 37,500 (Direct) |
View |
| 2018-08-01 Exercise |
2018-08-03 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W See Remarks |
37,500 | $0 | 37,500 (Direct) |
View |
| 2018-07-03 Exercise |
2018-07-05 6:25 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director |
5,816 | $5.59 | 88,017 (Direct) |
View |
| 2018-07-03 Exercise |
2018-07-05 6:25 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director |
1,684 | $5.59 | 88,017 (Direct) |
View |
| 2018-07-03 Exercise |
2018-07-05 6:25 pm |
N/A 2025-11-04 |
CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director |
5,816 | $5.59 | 88,017 (Direct) |
View |
| 2018-07-03 Exercise |
2018-07-05 6:25 pm |
N/A 2025-11-04 |
CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director |
1,684 | $5.59 | 88,017 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 4:55 pm |
N/A 2028-06-15 |
CRISPR Therapeutics AG | CRSP | George Simeon Director |
15,000 | $59.31 | 15,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-18 4:21 pm |
N/A 2028-06-15 |
CRISPR Therapeutics AG | CRSP | EMSTER KURT VON Director |
15,000 | $59.31 | 15,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-15 9:46 pm |
N/A 2028-06-15 |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
15,000 | $59.31 | 15,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-15 9:41 pm |
N/A 2028-06-15 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
32,000 | $59.31 | 32,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-15 9:40 pm |
N/A 2028-06-15 |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
30,000 | $59.31 | 30,000 (Indirect) |
View |
| 2018-06-15 Option Award |
2018-06-15 9:39 pm |
N/A 2028-06-15 |
CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director |
30,000 | $59.31 | 30,000 (Indirect) |
View |
| 2018-06-15 Option Award |
2018-06-15 9:38 pm |
N/A 2028-06-15 |
CRISPR Therapeutics AG | CRSP | Ho Tony W See Remarks |
43,000 | $59.31 | 43,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-15 9:37 pm |
N/A 2028-06-15 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN CFO |
20,760 | $59.31 | 20,760 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-15 9:36 pm |
N/A 2028-06-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO |
109,000 | $59.31 | 109,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-15 9:35 pm |
N/A 2018-06-15 |
CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director |
15,000 | $59.31 | 15,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 20 Jun 2019 10:20:11 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |